XBiotech Inc
SWB:4XB
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
X
|
XBiotech Inc
SWB:4XB
|
US |
|
S
|
Sinopharm Group Co Ltd
F:X2S
|
CN |
|
N
|
National Bank of Canada
XMUN:NBC
|
CA |
|
A
|
Adler Group SA
SWB:ADJ
|
LU |
|
Hill and Smith PLC
LSE:HILS
|
UK |
|
P
|
PostNL NV
DUS:TNTC
|
NL |
Intrinsic Value
Is 4XB undervalued or overvalued?
See the intrinsic value estimate for
XBiotech Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What XBiotech Does
XBiotech is a biotechnology company that develops antibody-based medicines, especially fully human monoclonal antibodies. Its work starts in the lab, where it identifies antibodies that can block disease pathways, and then it moves those candidates through testing and clinical trials. The company’s main goal is to turn those research programs into approved therapies for serious diseases such as cancer, inflammatory disorders, and infections.
- Headquarters
- United States of America US
- Employees
- 85
- IPO date
- Apr 15, 2015
Revenue & Expenses Breakdown
XBiotech Inc
Earnings Waterfall
XBiotech Inc
The intrinsic value for
XBiotech Inc (4XB) under the Base Case is hidden EUR.
Compared with the current market price of 2.065 EUR, the stock appears hidden.